Bioulac-Sage Paulette, Balabaud Charles, Zucman-Rossi Jessica
Hôpital Pellegrin, CHU de Bordeaux, France.
Ann Pathol. 2010 Dec;30(6):439-47. doi: 10.1016/j.annpat.2010.10.005. Epub 2010 Nov 27.
In this review, we focus on the interest of immunohistochemistry first, to differentiate the two types of benign hepatocellular nodules: focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) and second, to recognize the different subtypes of HCA: HNF1α inactivated HCA, β-catenin activated HCA and inflammatory HCA. This pathomolecular classication followed the study of genotype/phenotype correlations which led to the identification of immunohistochemical data characteristic of each subgroup. Immunohistochemical characteristics described on resected specimen are suitable on biopies of these tumors, facilitating their diagnosis and therefore allowing a better management of the patients.
在本综述中,我们首先关注免疫组织化学在鉴别两种良性肝细胞结节方面的作用,即局灶性结节性增生(FNH)和肝细胞腺瘤(HCA);其次关注其在识别HCA不同亚型方面的作用,即HNF1α失活型HCA、β-连环蛋白激活型HCA和炎症型HCA。这种病理分子分类是基于对基因型/表型相关性的研究,该研究导致了每个亚组特征性免疫组织化学数据的识别。在切除标本上描述的免疫组织化学特征适用于这些肿瘤的活检,有助于其诊断,从而实现对患者更好的管理。